These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23429762)

  • 41. Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder.
    Lee J; Lee KH; Kim SH; Han JY; Hong SB; Cho SC; Kim JW; Brent D
    J Affect Disord; 2020 Mar; 265():325-332. PubMed ID: 32090756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
    Hwang JP; Tsai SJ; Hong CJ; Yang CH; Lirng JF; Yang YM
    Neurobiol Aging; 2006 Dec; 27(12):1834-7. PubMed ID: 16343697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
    Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between the BDNF Val66Met Polymorphism and Chronicity of Depression.
    Lee Y; Lim SW; Kim SY; Chung JW; Kim J; Myung W; Song J; Kim S; Carroll BJ; Kim DK
    Psychiatry Investig; 2013 Mar; 10(1):56-61. PubMed ID: 23482723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users.
    Roviš D; Černelič Bizjak M; Vasiljev Marchesi V; Petelin A; Jenuš T; Vidic S; Drevenšek G; Jenko Pražnikar Z
    Eur Addict Res; 2018; 24(4):189-200. PubMed ID: 30134233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients.
    Iga J; Ueno S; Yamauchi K; Numata S; Tayoshi-Shibuya S; Kinouchi S; Nakataki M; Song H; Hokoishi K; Tanabe H; Sano A; Ohmori T
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1003-6. PubMed ID: 17510948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BDNF Val66Met and clinical response to antipsychotic drugs: A systematic review and meta-analysis.
    Cargnin S; Massarotti A; Terrazzino S
    Eur Psychiatry; 2016 Mar; 33():45-53. PubMed ID: 26854986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal.
    Cosci F; Chouinard VA; Chouinard G
    Psychother Psychosom; 2024 Jul; ():1-6. PubMed ID: 39043160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder.
    Atake K; Yoshimura R; Hori H; Katsuki A; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    Clin Psychopharmacol Neurosci; 2014 Apr; 12(1):37-40. PubMed ID: 24851119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients.
    Losenkov IS; Mulder NJV; Levchuk LA; Vyalova NM; Loonen AJM; Bosker FJ; Simutkin GG; Boiko AS; Bokhan NA; Wilffert B; Hak E; Schmidt AF; Ivanova SA
    Front Psychiatry; 2020; 11():38. PubMed ID: 32116853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.
    Yoshimura R; Kishi T; Hori H; Atake K; Katsuki A; Nakano-Umene W; Ikenouchi-Sugita A; Iwata N; Nakamura J
    Ann Gen Psychiatry; 2014; 13():19. PubMed ID: 25089150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of the Val66Met polymorphism of the
    Haldar S; Roy S; Sen S; Dasgupta A; Ghosh S
    Indian J Psychiatry; 2022; 64(3):269-276. PubMed ID: 35859549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations between Autoimmunity and Depression: Serum IL-6 and IL-17 Have Directly Impact on the HAMD Scores in Patients with First-Episode Depressive Disorder.
    Mao L; Ren X; Wang X; Tian F
    J Immunol Res; 2022; 2022():6724881. PubMed ID: 35615531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study.
    Yoshimura R; Kishi T; Atake K; Katsuki A; Iwata N
    Front Psychiatry; 2018; 9():52. PubMed ID: 29541037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs).
    Takahashi N; Ikeda K; Iwai G; Shinbori K; Baba H; Sasaki T; Takahashi K; Morita Y; Horii A
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1483-1489. PubMed ID: 33388987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma Neurotrophic Factor Levels are not Associated with the Severity of Depression: Prospective Pilot Study.
    Zorkina YA; Syunyakov TS; Abramova OV; Yunes RA; Pavlichenko AV; Pavlov KA; Khobta EB; Susloparova DA; Tsarapkin GY; Andreyuk DS; Danilenko VN; Gurina OI; Morozova AY
    Consort Psychiatr; 2021; 2(4):13-22. PubMed ID: 39045452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum NLRP3 Inflammasome and BDNF: Potential Biomarkers Differentiating Reactive and Endogenous Depression.
    Yang XJ; Zhao BC; Li J; Shi C; Song YQ; Gao XZ; Jiang HL; Yu QY; Liang XC; Feng SX; Li X; Sun Y; Li YH; Wang YP; Bao T; Zhang ZJ
    Front Psychiatry; 2022; 13():814828. PubMed ID: 35295780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of BDNF Val66Met Polymorphism on White Matter Microalterations of the Corpus Callosum in Patients with Panic Disorder in Korean Populations.
    Kim HJ; Bang M; Lee KS; Choi TK; Park CI; Lee SH
    Psychiatry Investig; 2021 Nov; 18(11):1144. PubMed ID: 34788528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.